Peri-implant Disease and Prosthetic Cement: Cross-sectional Study

Sponsor
University of Bologna (Other)
Overall Status
Completed
CT.gov ID
NCT05945836
Collaborator
(none)
46
1
8.6
5.3

Study Details

Study Description

Brief Summary

The main objective of the present clinical study project, of a cross-sectional observational nature, is to evaluate the presence of submucosal cement residues through endoscopic visualization in clinical situations with peri-implant disease.

The secondary objective is to investigate the potential correlation between the severity of the pathological condition and the spatial position of cement residues in relation to the implant-prosthetic unit.

For each subject, the following data were collected: gender, age, periodontal history, smoking habits, reasons for implant rehabilitation (trauma, caries, periodontitis, agenesis, other), the position of the implant in the oral cavity, elapsed time between prosthetic rehabilitation and pathological condition. If the deposit was recognized as cement residue, its presence was recorded, and the anatomical position of the cement residue (mesial, distal, lingual/palatal, vestibular) and the spatial position of cement residues in relation to the implant-prosthetic unit were collected.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    46 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Excess Cement and Peri-implant Disease: A Cross-sectional Clinical Endoscopic Study
    Actual Study Start Date :
    Oct 29, 2018
    Actual Primary Completion Date :
    Jul 19, 2019
    Actual Study Completion Date :
    Jul 19, 2019

    Outcome Measures

    Primary Outcome Measures

    1. Prevalence of submucosal cement [The analysis was conducted during the endoscopic examination between October 29, 2018, and July 19, 2019.]

      A clinical examination of the submarginal implant area was performed using endoscopic techniques (DV2, Dental View, Irvine, CA). The analysis was conducted in an atraumatic manner, and local anesthesia infiltration (2% Mepivacaine with 1:100,000 adrenaline) was administered only upon patient request. During the endoscopic investigation, once a deposit was identified, its consistency and adhesion were assessed using water irrigation or, less frequently, a probe. Only for solid deposits, a differential analysis between calculus and cementum was conducted. Cementum was identified by its characteristic white reflectivity, in contrast to subgingival calculus, which appeared yellow or brown, depending on the intensity and distance of the incident light beam.

    Secondary Outcome Measures

    1. Spatial position of submucosal cement [The analysis was conducted during the endoscopic examination between October 29, 2018, and July 19, 2019.]

      If the deposit was recognized as cement residue, its presence was recorded, and the following clinical data were collected: Distance between mucosal margin and prosthetic closure margin at the site of the cement residue: MM-PM = Mucosal Margin - Prosthetic Margin Distance between prosthetic closure margin and implant platform at the site of the cement residue: PM-IP = Prosthetic Margin - Implant Platform Distance between the most apical portion of the cement residue and implant platform: AC-IP = Apical Cement - Implant Platform

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • at least one single-implant with cemented restoration and clinical-radiographic signs of peri-implant disease

    • patients with previous periodontitis had to have a healthy but reduced periodontium

    Exclusion Criteria:
    • neuromotor pathologies or morphological-dysfunctional alterations

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Alma Mater Studiorum - University of Bologna, Department of Biomedical and Neuromotor Sciences, School of Dentistry - Division of Periodontology and Implantology. Bologna Italy 40120

    Sponsors and Collaborators

    • University of Bologna

    Investigators

    • Study Chair: Marco Montevecchi, DDS, Alma Mater Studiorum - University of Bologna

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marco Montevecchi, Assistant professor, University of Bologna
    ClinicalTrials.gov Identifier:
    NCT05945836
    Other Study ID Numbers:
    • peri-implant/cement
    First Posted:
    Jul 14, 2023
    Last Update Posted:
    Jul 19, 2023
    Last Verified:
    Jul 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Marco Montevecchi, Assistant professor, University of Bologna
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 19, 2023